Typhoid Vaccine Live

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Typhoid Vaccine Live
Accession Number
DB11050
Description

Salmonella typhi Ty21a live antigen is a live attenuated vaccine for oral administration only. It contains the attenuated strain Salmonella typhi Ty21a. The vaccine prevents the development of typhoid fever, an acute, febrile enteric disease caused by Salmonella typhi by inducing a local immune response in the intestinal tract.

Type
Biotech
Groups
Approved
Biologic Classification
Vaccines
Attenuated
Synonyms
  • Salmonella enterica subsp. enterica serovar typhi
  • Salmonella typhi Ty21a live antigen
  • Typhoid vaccine (salmonella typhi Ty21a)
  • Typhoid Vaccine Live Ty21a

Pharmacology

Pharmacology
Accelerate your drug discovery research with the industry’s only fully connected ADMET dataset, ideal for:
Machine Learning
Data Science
Drug Discovery
Accelerate your drug discovery research with our fully connected ADMET dataset
Learn more
Indication
Not Available
Associated Conditions
Contraindications & Blackbox Warnings
Contraindications
Contraindications & Blackbox Warnings
With our commercial data, access important information on dangerous risks, contraindications, and adverse effects.
Learn more
Our Blackbox Warnings cover Risks, Contraindications, and Adverse Effects
Learn more
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half-life
Not Available
Clearance
Not Available
Adverse Effects
Medicalerrors
Reduce medical errors
and improve treatment outcomes with our comprehensive & structured data on drug adverse effects.
Learn more
Reduce medical errors & improve treatment outcomes with our adverse effects data
Learn more
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbacavirThe therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Abacavir.
AbataceptThe risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Abatacept.
AcyclovirThe therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Acyclovir.
AdalimumabThe risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Adalimumab.
Adefovir dipivoxilThe therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Adefovir dipivoxil.
AldesleukinThe risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Aldesleukin.
AlefaceptThe risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Alefacept.
AlemtuzumabThe risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Alemtuzumab.
AltretamineThe risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Altretamine.
AmantadineThe therapeutic efficacy of Typhoid Vaccine Live can be decreased when used in combination with Amantadine.
Interactions
Improve patient outcomes
Build effective decision support tools with the industry’s most comprehensive drug-drug interaction checker.
Learn more
Food Interactions
Not Available

Products

Products
Comprehensive & structured drug product info
From application numbers to product codes, connect different identifiers through our commercial datasets.
Learn more
Easily connect various identifiers back to our datasets
Learn more
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
VivotifCapsule, coated6000000000 [CFU]/1OralPaxvax Berna Gmbh1992-03-16Not applicableUS flag
VivotifCapsule, delayed release10000000000 [CFU]OralEmergent Travel Health Inc.1993-01-01Not applicableCanada flag
VivotifCapsule, coated2 [CFU]/1[CFU]OralA-S Medication Solutions1992-03-16Not applicableUS flag
VivotifCapsule, coated6000000000 [CFU]/1OralA-S Medication Solutions1992-03-16Not applicableUS flag
Vivotif LPowderOralBerna Biotech Ltd1997-11-012015-11-01Canada flag

Categories

Drug Categories
Classification
Not classified

Chemical Identifiers

UNII
760T5R8B3O
CAS number
Not Available

References

General References
Not Available
PubChem Substance
347911093
RxNav
762595
AHFS Codes
  • 80:12.00 — Vaccines

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4Active Not RecruitingBasic ScienceFlu caused by Influenza / Healthy Adults / Hepatitis A / Salmonella Typhi Infection1
4RecruitingBasic ScienceRisk Reduction1
4RecruitingBasic ScienceTyphoid and/or Cholera Vaccination1
4RecruitingBasic ScienceTyphoid Vaccination1
4Unknown StatusPreventionHealthy Volunteers1
2Active Not RecruitingPreventionSalmonella Typhi Infection1
2TerminatedTreatmentUlcerative Colitis1
0Not Yet RecruitingBasic ScienceInflammatory Reaction / Intestinal Permeability / Salmonella Typhi Infection / Vaccines1
0RecruitingBasic ScienceInflammatory Reaction / Intestinal Permeability / Salmonella Typhi Infection / Vaccines1
Not AvailableCompletedNot AvailableSalmonella Typhi Infection1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Capsule, coatedOral2 [CFU]/1[CFU]
Capsule, coatedOral6000000000 [CFU]/1
Capsule, delayed releaseOral
Capsule, delayed releaseOral10000000000 [CFU]
CapsuleOral
Capsule, coatedOral
PowderOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on December 01, 2015 20:05 / Updated on April 21, 2021 00:36